RARE

Ultragenyx Pharmaceutical Inc. (RARE) is a prominent biopharmaceutical company based in Novato, California, focused on the development of innovative therapies for patients with rare and ultra-rare genetic disorders. The firm is dedicated to addressing critical unmet medical needs through a diverse pipeline that includes gene therapies and enzyme replacement therapies. With a patient-centric ethos, Ultragenyx prioritizes the needs of the rare disease community in its research and commercialization efforts. The company's commitment to delivering transformative treatment options aims to significantly improve the quality of life and outcomes for individuals affected by these complex conditions.